BlogThe systemic gaps in Women’s Parkinson’s The systemic gaps in Women’s Parkinson’s Posted Date : Mar 9, 2026 For decades, the public image of Parkinson’s has largely been shaped by how it appears in men. But Parkinson’s does not affect everyone the same way. For many women, symptoms look different, fluctuate differently, and are experienced within very different social realities. When the system is built around a male-centered understanding of the disease, women are left navigating a gap – in recognition, diagnosis, treatment, and support. That gap has consequences. When symptoms don’t fit the “typical” picture Women with Parkinson’s often experience more non-motor symptoms, including anxiety, depression, pain, fatigue, and apathy. They may experience less rigidity and fewer of the motor changes traditionally associated with Parkinson’s. Because of this, symptoms can be overlooked, downplayed, or attributed to stress, aging, or other conditions. Some women face delayed or missed diagnoses. Others spend years trying to make sense of symptoms that don’t match what they’ve been told Parkinson’s “should” look like. When the clinical picture is narrow, those who don’t fit it fall through the cracks. Hormones are rarely part of routine care Hormonal changes across a woman’s life can influence how Parkinson’s symptoms appear and fluctuate. Many women notice worsening symptoms before their period. Others experience symptom changes around menopause, when sleep disruption, anxiety, fatigue, and mood changes overlap with Parkinson’s symptoms. Estrogen shifts may influence symptom intensity before and after menopause. Yet hormonal factors are not routinely discussed in Parkinson’s care. When a major biological factor in women’s health is absent from standard care conversations, women are left to track patterns and advocate for tailored care on their own. That is not a small oversight – it is a structural gap. The invisible load women carry Women with Parkinson’s often continue to carry caregiving roles, professional responsibilities, and emotional labour while managing their own symptoms. Many describe difficulty asking for help, especially if they have long identified as caregivers. Anxiety and depression are more common. Changes in mobility, speech, or facial expression can affect confidence and self-image. Social situations may feel more overwhelming. When healthcare systems do not fully account for these realities, women are expected to adapt to the system, rather than the system adapting to them. Why this matters A systemic gap does not mean individuals are failing. It means the structure itself was not designed with everyone in mind. When women are diagnosed later, misunderstood, or not fully heard, the impact ripples outward – affecting mental health, employment, family dynamics, and long-term wellbeing. Equitable care requires recognizing that women’s experiences are distinct – and that those differences deserve attention, validation, and action. Closing the gap starts with awareness and with amplifying women’s lived experiences. Here’s how you can help: Read and share women’s lived experiences Personal stories reveal what statistics cannot. They show the emotional realities, the invisible struggles, and the strength women bring to navigating Parkinson’s. Read and share some of the lived experience blogs we’ve created. They help shift the narrative, ensuring women’s voices are part of how Parkinson’s is understood. We’ve also created a resource that helps shine a light on the reality of how women are differently affected by Parkinson’s. Meet the women who inspire us Read their powerful stories and get a glimpse of life with Parkinson’s as a woman. Share this post: Your story matters: inspire and connect Inspire hope and connect with others by sharing your Parkinson’s journey. Your voice can make a difference. Share your story Discover more like this Apr 15, 2026 2026 Annual General Meeting notice Apr 8, 2026 Boxing for Parkinson’s: An architect’s fight and a studio’s discovery Apr 7, 2026 Beyond pills: exploring advanced therapies for Parkinson’s